• SENSEX 78,079.96
    113.61 (+0.15%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • UltraTech Cem.
    11,575.00 10,329.00(%)
  • JSW Energy
    562.05 617.30(%)
  • Urban Company
    146.00 201.00(%)
  • HDFC Bank
    724.45 722.00(%)
  • ICICI Bank
    1,406.60 1,187.55(%)
  • Reliance Industries
    1,307.10 1,250.55(%)
  • Larsen & Toubro
    4,070.00 4,440.00(%)
  • Bharti Airtel
    1,970.05 2,174.70(%)
  • Godrej Consumer
    938.90 1,308.40(%)
  • Netweb Technol.
    5,200.00 5,241.65(%)
  • Thyrocare Tech.
    594.30 342.55(%)
  • Fortis Health.
    904.95 1,105.00(%)
  • SBI
    1,073.20 798.60(%)
  • Astral
    1,599.00 1,767.95(%)
  • M & M
    3,440.00 3,840.00(%)
  • ITC
    279.50 426.50(%)
  • Cupid
    295.00 290.00(%)
  • Bajaj Finserv
    2,037.00 2,194.65(%)
  • Axis Bank
    1,215.30 1,041.30(%)
  • Solar Industries
    20,400.00 19,160.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Caplin Point Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4464.0
  • ISIN : INE475E01026
2,472.40 -157 (-5.98%)
  • As on 13 Aug 2026 (EOD)

  • Today’s Low

    2,452.00

  • Today’s High

    2,672.10

  • Open

    2,629.60

  • Perv Close

    2,629.60

  • 52W Low

    1,500.30

  • 52W High

    2,699.00

Key Indicators

  • P/E(TTM)

    47.44

  • Mar.Cap (₹Cr.)

    18,793.13

  • Div & Yield %

    0.16

  • Book Value(₹)

    269.76

  • Debt-Equity Ratio

    -5.98

  • AGM Date

    12-Aug-2026

  • EPS

    52.17

  • P/E Ratio

    47.44

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    18,793.13

  • RONW (%)

    24.52

  • ROCE (%)

    26.67

Score Board

  • Equity (₹ in Cr.)

    15.20

  • BV (₹)

    269.80

  • Sales( ₹ in Cr.)

    738.33

  • NP (in Cr.)

    396.58

  • NP Var(%)

    17.0

  • Div%

    200.0

  • CPS (₹)

    55.50

  • EPS (₹)

    52.20

  • Traded Value (₹ in Lakhs)

    18,814.41

  • 52 Week High

    2,699.00

  • 52 Week Low

    1,500.30

  • Price BSE

    2475.0

  • Price NSE

    2,472.00

  • Market Capital( in Cr.)

    18,814.41

  • P/C Ratio

    44.60

  • P/E Ratio

    47.40

  • Price Vs.BV

    52.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 752.41 625.09 528.61 528.06 482.68 527.83
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 752.41 625.09 528.61 528.06 482.68 527.83
Other Income 134.59 105.84 99.00 56.55 18.62 65.97
Stock Adjustments -24.36 43.68 1.67 9.00 0.57 0.74
Total Income 862.64 774.61 629.28 593.61 501.87 594.54
EXPENDITURE :            
Raw Materials 213.81 248.90 199.73 213.65 195.40 238.92
Power and Fuel Cost 14.11 15.43 9.89 9.54 6.36 7.19
Employee Cost 52.13 38.11 36.68 30.47 26.59 25.00
Other Manufacturing Expenses 24.00 25.43 13.73 10.81 7.75 8.98
Selling and Administration Expenses 75.50 40.75 40.30 43.51 28.12 38.19
Miscellaneous Expenses 16.53 13.07 10.03 9.46 5.10 3.29
Employee Benefit Expenses 52.13 38.11 36.68 30.47 26.59 25.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 396.08 381.69 310.36 317.44 269.32 321.57
Operating Profit 466.56 392.92 318.92 276.17 232.55 272.97
Interest 0.12 0.10 0.12 0.09 0.17 0.19
Gross Profit 466.44 392.82 318.80 276.08 232.38 272.78
Depreciation 24.77 27.08 25.65 25.77 22.44 19.65
Profit Before Tax 441.67 365.74 293.15 250.31 209.94 253.13
Current Tax 102.90 86.12 66.58 61.62 54.88 55.89
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.72 -4.09 -7.69 0.82 -1.17 -0.40
Reported Net Profit 339.49 283.71 234.26 187.87 156.23 197.64
Extraordinary Items -0.33 1.19 1.17 0.75 4.67 3.75
Adjusted Net Profit 339.82 282.52 233.09 187.12 151.56 193.89
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,333.49 1,083.95 880.01 714.84 561.64 396.53
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 37.99 34.17 30.32 22.70 3.03 32.53
P & L Balance carried down 1,634.99 1,333.49 1,083.95 880.01 714.84 561.64
Dividend 18.99 15.19 15.16 11.35 0.00 15.88
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 300.00 250.00 225.00 200.00 150.00 125.00
Dividend Per Share(Rs) 6.00 5.00 4.50 4.00 3.00 2.50
Earnings Per Share-Unit Curr 44.67 37.35 30.86 24.78 20.65 26.13
Earnings Per Share(Adj)-Unit Curr 44.67 37.35 30.86 24.78 20.65 26.13
Book Value 223.81 183.03 150.19 122.78 100.29 79.31
Book Value(Adj)-Unit Curr 223.81 183.03 150.19 122.78 100.29 79.31

Shareholding Pattern

  • Promoter Group

    70.57%

  • Public Share Holding

    29.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,637,000 3.47 2,637,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 51,005,353 67.10 51,005,353 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 53,642,353 70.57 53,642,353 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1 0.00 1 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,550 0.00 3,550 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,373,994 5.75 4,373,994 147
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 22,204 0.03 22,204 2
Mutual Funds / UTI 1,540,686 2.03 1,540,686 19
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 329,117 0.43 329,117 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,269,552 8.25 6,269,552 185
2] Non Institution
Bodies Corporate 1,187,868 1.56 1,187,368 612
Clearing Members 0 0.00 0 0
Directors of their Relatives 7,000 0.01 7,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,047,402 1.38 1,042,402 3,192
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 323,652 0.43 323,652 1,330
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,883,490 2.48 1,883,490 32
Individuals holding nominal share capital up to Rs. 1 lakh 9,231,283 12.14 8,695,658 89,013
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 8,846 0.01 8,846 7
Others 2,348,235 3.09 2,298,235 5
Sub Total 16,099,791 21.18 15,508,666 94,193
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,011,696 100.00 75,420,571 94,385

Company Background

Caplin Point Laboratories LtdPharmaceuticals - Indian - Formulations

  • Caplin Point Laboratories Ltd
  • BSE Code : 4464.0
  • ISIN : INE475E01026

  • Incorporation Year

    1990

  • Registered Office

    Ashvich Towers 3rd Floor
    No 3 Developed Plots Ind Estat, Chennai,
    Tamil Nadu-600096

  • Telephone

    91-44-24968000/71148000/28156653

  • FAX

    91-44-28154952

  • Chairman

    C C Paarthipan

  • Managing Director

  • Company Secretary

  • Auditor

    Brahmayya & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Registry Mgt Ser.Pv
    2nd Floor Kences Tow,
    1 Ramakrishna Street,Usman Road T.Nagar
    Mumbai - Chennai-600017

Caplin Point Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Caplin Point Lab 2,475.20 887.00 752.41 47.44 28.50
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77